FIORE, MICHELE
 Distribuzione geografica
Continente #
AS - Asia 6.708
NA - Nord America 841
EU - Europa 639
SA - Sud America 123
AF - Africa 23
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.343
Nazione #
SG - Singapore 5.870
US - Stati Uniti d'America 803
CN - Cina 491
IT - Italia 227
HK - Hong Kong 163
DE - Germania 104
GB - Regno Unito 94
BR - Brasile 92
VN - Vietnam 82
FI - Finlandia 44
EE - Estonia 43
NL - Olanda 34
IN - India 30
ID - Indonesia 22
CA - Canada 19
ZA - Sudafrica 15
AR - Argentina 14
AT - Austria 13
UA - Ucraina 12
CZ - Repubblica Ceca 11
FR - Francia 11
MX - Messico 11
JP - Giappone 9
RU - Federazione Russa 9
AU - Australia 8
BD - Bangladesh 8
RO - Romania 8
SE - Svezia 8
TR - Turchia 8
EC - Ecuador 6
PL - Polonia 5
ES - Italia 4
IQ - Iraq 4
CL - Cile 3
IL - Israele 3
LT - Lituania 3
PY - Paraguay 3
TW - Taiwan 3
UZ - Uzbekistan 3
BE - Belgio 2
BG - Bulgaria 2
CM - Camerun 2
CO - Colombia 2
KZ - Kazakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BB - Barbados 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GF - Guiana Francese 1
GP - Guadalupe 1
HT - Haiti 1
HU - Ungheria 1
KE - Kenya 1
KR - Corea 1
KW - Kuwait 1
LY - Libia 1
MA - Marocco 1
ML - Mali 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PS - Palestinian Territory 1
RE - Reunion 1
RS - Serbia 1
SA - Arabia Saudita 1
SL - Sierra Leone 1
TJ - Tagikistan 1
TL - Timor Orientale 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.343
Città #
Singapore 331
Hefei 200
Ashburn 184
Dallas 159
Hong Kong 158
Beijing 132
Rome 106
Boardman 83
London 82
Munich 68
Shanghai 66
Council Bluffs 46
Los Angeles 38
Ho Chi Minh City 33
Amsterdam 24
Helsinki 23
Turku 21
San Francisco 18
Hanoi 15
São Paulo 15
Milan 14
Sona 14
Washington 14
New York 11
Pune 11
Toronto 11
Boston 10
Santa Clara 10
Atlanta 9
Brno 9
Brooklyn 9
Seattle 9
Chicago 8
West Jordan 8
Nuremberg 7
Johannesburg 6
Mexico City 6
Redmond 6
Tokyo 6
Ankara 5
Chennai 5
Haiphong 5
Naples 5
Rocca di Papa 5
Buenos Aires 4
Buffalo 4
Cascina 4
Denver 4
Rio de Janeiro 4
Umeå 4
Vicenza 4
Warsaw 4
Aprilia 3
Bologna 3
Bình Dương 3
Catania 3
Central 3
Frankfurt am Main 3
Guangzhou 3
Guayaquil 3
Handan 3
Hangzhou 3
Hanover 3
Hải Dương 3
Jakarta 3
Melbourne 3
Montreal 3
Phoenix 3
Secaucus 3
Stockholm 3
Sydney 3
Tashkent 3
Vaddangi 3
Vienna 3
Albignasego 2
Bangalore 2
Banqiao 2
Baoding 2
Bismarck 2
Bratislava 2
Brussels 2
Bucharest 2
Canberra 2
Charleston 2
Harbin 2
Irecê 2
Jacksonville 2
Liberty Lake 2
Manchester 2
Markham 2
Monte San Giusto 2
New Delhi 2
Ninh Bình 2
Olomouc 2
Palermo 2
Pescara 2
Providence 2
Quarrata 2
Quito 2
Rio Brilhante 2
Totale 2.155
Nome #
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up 300
Deep pathomics: A new image-based tool for predicting response to treatment in stage III non-small cell lung cancer 242
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 231
A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra–target-tissue irradiation 208
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 199
Exploring Deep Pathomics in Lung Cancer 199
Delayed surgery after radio-chemotherapy for rectal adenocarcinoma is protective for anastomotic dehiscence: a single-center observational retrospective cohort study 194
Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review 193
Estimating the value of surgical clips for target volume delineation in external beam partial breast radiotherapy 193
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 193
Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system. 192
Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy 192
Clinical practice guidelines for diagnosis, treatment and follow-up of exocrine pancreatic ductal adenocarcinoma: Evidence evaluation and recommendations by the italian association of medical oncology (AIOM) 190
Delayed surgery after radio-chemotherapy for rectal adenocarcinoma is protective for anastomotic dehiscence: a single centre retrospective analysis 190
Clinical results of stereotactic ablative radiotherapy in the treatment of liver metastases 190
A bio-imaging signature as a predictor of clinical outcomes in locally advanced pancreatic cancer 188
Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift 187
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy. 186
Histologic transformation to small-cell lung cancer following gefitinib and radiotherapy in a patient with pulmonary adenocarcinoma. 181
Preventing Cardiotoxicity in Personalized Breast Irradiation 177
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 176
The role of multiparametric magnetic resonance imaging in the diagnosis of local recurrence after radical prostatectomy and before salvage radiotherapy 147
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 129
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 118
Ablative Five-Fraction Stereotactic Radiotherapy in Elderly Patients with Pancreatic Cancer: A Single Institution Experience 111
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 108
The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies 107
CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis 106
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 105
Radiation-induced pneumonitis in the era of the covid-19 pandemic: artificial intelligence for differential diagnosis 104
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 103
Long term results of a prospective phase 2 study on volume de-escalation in neoadjuvant chemoradiotherapy of rectal cancer 103
Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer 101
Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer 100
Factors predicting pathological response to neoadjuvant chemoradiotherapy in rectal cancer: The experience of a single institution with 269 patients (STONE-01) 99
The psychological impact of the covid-19 pandemic on radiotherapy cancer patients 97
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 97
Beams arrangement in non small-cell lung cancer (NSCLC) according to PTV and dosimetric parameters predictive of pneumonitis 96
Breast Volume Is a Predictor of Higher Heart Dose in Whole-Breast Supine Free-Breathing Volumetric-Modulated Arc Therapy Planning 93
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 92
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection 87
Chemoradiation for stage III non-small cell lung cancer 86
Different biliary microbial flora influence type of complications after pancreaticoduodenectomy: a single center retrospective analysis 84
Addressing the crisis: the looming shortage of radiation oncologists and the urgency for action 83
A Multimodal Ensemble Driven by Multiobjective Optimisation to Predict Overall Survival in Non-Small-Cell Lung Cancer 79
A clinical score, including biohumoral parameters, is a useful pretest index to discriminate pulmonary infections from radiation damage in chemoradiation-treated lung cancer patients 74
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). 72
A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients 70
COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases 68
Exploratory Radiomics for Predicting Adaptive Radiotherapy in Non-Small Cell Lung Cancer 67
Precision radiotherapy by SPECT lung functional imaging in NSCLC 49
Empowering Hepatocellular Carcinoma Ablative Therapy: A Renaissance of Collaboration 45
Doctor-in-the-Loop: An explainable, multi-view deep learning framework for predicting pathological response in non-small cell lung cancer 45
Special Issue “Hepatobiliary and Pancreatic Cancers: Novel Strategies for of Diagnosis and Treatments” 42
Efficacy of a Propolis-Based Syrup (FARINGEL) in Preventing Radiation-Induced Esophagitis in Locally Advanced Lung Cancer. 41
Protective Role of Natural Compounds under Radiation-Induced Injury 40
NeoAdjuvant chemoradiation for pancreatic cancer results of an ongoing trial 39
Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC 37
In Reply to Riou et al 36
Pancreatic cancer care: Lighting the way with the torch of staging laparoscopy and advanced imaging 35
Radiation treatment for adult rare cancers: Oldest and newest indication 35
In Regard to Parikh et al 34
Neutrophil to lymphocyte ratio (NLR) and derived neutrophil to lymphocyte ratio (D-NLR) predict non-responders and postoperative complications in patients undergoing radical surgery after neo-adjuvant radio-chemotherapy for rectal adenocarcinoma 34
RADIOCHEMOTHERAPY FOR LOCALLY-ADVANCED NSCLC: WHICH IS THE BEST ASSOCIATION? FROM CHEMOTHERAPY TO BIOLOGICAL TARGET IN 5 PHASES II TRIALS 32
Heterotopic hip ossification resection: monocentric experiences of associated factors, outcomes, and complications 31
The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani) 29
Neoadjuvant chemoradiation in locally advanced NSCLC: impact of histology and drugs on results. 28
Molecularly targeted therapy and radiotherapy in the management of localized gastrointestinal stromal tumor (GIST) of the rectum: a case report 28
MULTIMODALITY TREATMENT WITH RADIOCHEMOTHERAPY AND ERLOTINIB IN ADVANCED NSCLC (MARTE TRIAL). 28
PATTERN OF FAILURE AFTER ADAPTIVE RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (LA-NSCLC). 27
Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives 26
Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity. 26
¹⁸F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients 26
SBRT: A viable option for treating adrenal gland metastases 26
Whole-Breast Irradiation: A Subgroup Analysis of Criteria to Stratify for Prone Position Treatment 26
Preliminary results of a phase II study of induction Folfirinox followed by chemoradiation in LAPC 25
OA24.02 - Locally Advanced Non-Small Cell Lung Cancer: RadioTherapy with Adaptive Strategy (LARTIA Trial) 25
PV-0276 Adaptive radiotherapy: rate of "marginal" failure after "replanning" in combined treatment of NSCLC. 25
Somatostatin analogs and disease control in castration-resistant prostate cancer: different biological behavior? Case series and review of the literature 25
Induction chemotherapy with cisplatin, 5-fluorouracil, and cetuximab followed by radiotherapy and cetuximad in head and neck cancers: Preliminary results of a modern integrated approach 24
Stereotactic body radiation therapy for early stage NSCLC: clinical outcomes 24
Radiomics-based prediction of overall survival in lung cancer using different volumes-of-interest 24
Safety and efficacy of combined radiotherapy, immunotherapy and targeted agents in elderly patients: A literature review 23
Thoracic Radiotherapy in Extensive Disease Small Cell Lung Cancer: Multicenter Prospective Observational TRENDS Study 23
The role of mammography after breast-conserving surgery and adjuvant chemotherapy 23
Radiotherapy and vascular endothelial growth factor receptor-tyrosine kinase inhibitors in renal cancer 22
Erlotinib and concurrent chemoradiation in pretreated NSCLC patients: radiobiological basis and clinical results. 22
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 21
Role of induction therapy in esophageal cancer 21
Prognostic Score in Radiotherapy Practice for Palliative Treatments (PROPHET) Study for Bone Metastases: An Investigation Into the Clinical Effect on Treatment Prescription 18
Combined modality therapy for thoracic and head and neck cancers: A review of updated literature based on a consensus meeting 18
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 1 18
Multimodality treatment of stage III non-small cell lung cancer: analysis of a phase II trial using preoperative cisplatin and gemcitabine with concurrent radiotherapy 18
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2 17
Evaluation of Italian radiotherapy research from 1985 to 2005: preliminary analysis 17
Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case-control study (PAULA-1) 17
PAIDEIA: pacemaker and implanted cardioverter defibrillator management in radiation therapy—a survey by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 16
Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study 15
Volume de-escalation in radiation therapy: state of the art and new perspectives 15
Breast CancerTrastuzumab-deruxtecan and radiotherapy: a safety sub-analysis of combart prospective cohort study 15
Totale 8.343
Categoria #
all - tutte 40.829
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.829


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022117 0 1 2 4 1 3 5 3 13 1 0 84
2022/202379 0 1 2 3 6 1 22 6 7 0 22 9
2023/2024306 11 26 19 15 27 118 14 20 3 17 12 24
2024/20256.558 46 24 146 68 60 116 71 32 279 425 2.420 2.871
2025/20261.371 310 204 233 332 206 86 0 0 0 0 0 0
Totale 8.431